Skip to main content
Clinical Trials/ACTRN12623000251628
ACTRN12623000251628
Not yet recruiting
未知

Evaluation of biometric measurement agreement and precision of a HP-OCT (Hyperparallel Optical Coherence Tomography) device in normal eyes and eyes with diseases.

Cylite Pty Ltd0 sites70 target enrollmentMarch 8, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Cataracts
Sponsor
Cylite Pty Ltd
Enrollment
70
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 8, 2023
End Date
TBD
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cylite Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • oAge greater than or equal to 18 years
  • oParticipants with normal health eyes apart from specific recruitment categories
  • oParticipants will have best corrected visual acuity (logMAR 0\.00, 6/6 or better in each eye), unless they fall into the specific recruitment categories of cataract, intraocular lens or post\-refractive surgery

Exclusion Criteria

  • oNo history of ocular injury in the past 12 weeks
  • oNo use of ocular medications on the day of testing
  • oNo use of lubrication within an hour of testing
  • oNo soft contact lens wear on the testing day
  • oNo rigid contact lens wearers
  • oNo active ocular infection or inflammation
  • oNo eyelid pathology that may interfere with blinking including ptosis, entropian, ectropian, blepharitis, lid margin disease or chalazia
  • oNo history of eyelid surgery
  • oNo corneal conditions and diseases that may impair the topography pattern reflection such as keratoconus, central corneal scar or pterygia
  • oNo ocular posterior segment pathology which may affect their ability to fixate on the instrument’s fixation target (and therefore affect their ability to have high quality measurements obtained

Outcomes

Primary Outcomes

Not specified

Similar Trials